Oracle Investment Management as of Dec. 31, 2017
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 21 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Quidel Corporation | 24.9 | $108M | 2.5M | 43.35 | |
| Tesaro | 18.2 | $79M | 956k | 82.70 | |
| Mazor Robotics Ltd. equities | 15.4 | $67M | 1.3M | 51.60 | |
| Accelr8 Technology Corporation | 10.4 | $45M | 4.9M | 9.19 | |
| Amarin Corporation (AMRN) | 5.8 | $25M | 6.3M | 4.01 | |
| Pacific Biosciences of California (PACB) | 5.1 | $22M | 8.5M | 2.64 | |
| Vermillion | 4.4 | $19M | 9.8M | 1.93 | |
| Opko Health (OPK) | 4.3 | $19M | 3.8M | 4.90 | |
| Biolase Technology | 3.1 | $13M | 31M | 0.43 | |
| Adaptimmune Therapeutics (ADAP) | 1.6 | $6.9M | 1.0M | 6.68 | |
| shares Agenus | 1.2 | $5.0M | 1.5M | 3.26 | |
| Arena Pharmaceuticals | 1.1 | $4.8M | 141k | 33.97 | |
| Epizyme | 1.1 | $4.6M | 363k | 12.55 | |
| Soleno Therapeutics | 1.0 | $4.3M | 2.4M | 1.80 | |
| Contrafect | 0.7 | $2.9M | 2.9M | 1.01 | |
| Intrexon | 0.5 | $2.2M | 195k | 11.52 | |
| Biogen Idec (BIIB) | 0.5 | $2.0M | 6.4k | 318.62 | |
| Endologix | 0.5 | $1.9M | 363k | 5.35 | |
| Accuray Incorporated (ARAY) | 0.4 | $1.6M | 377k | 4.30 | |
| Second Sight Med Prods | 0.0 | $97k | 51k | 1.91 | |
| NxStage Medical | 0.0 | $4.3k | 143k | 0.03 |
